Last Updated: June 25, 2026

Suppliers and packagers for MYRBETRIQ GRANULES


✉ Email this page to a colleague

« Back to Dashboard


MYRBETRIQ GRANULES

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Apgdi MYRBETRIQ GRANULES mirabegron FOR SUSPENSION, EXTENDED RELEASE;ORAL 213801 NDA Astellas Pharma US, Inc. 0469-5020-99 1 BOTTLE in 1 CARTON (0469-5020-99) / 100 mL in 1 BOTTLE 2021-03-25
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for MYRBETRIQ GRANULES

Last updated: June 1, 2026

Myrbetriq Granules Suppliers: Who Manufactures and Supplies the Drug Product and API Across the Supply Chain

Executive summary: Suppliers for MYRBETRIQ granules (mirabegron oral granules) are concentrated in the contract manufacturing and API supply chain for the mirabegron drug substance and the finished dosage form sold under the MYRBETRIQ brand. Myrbetriq is marketed in the US by Astellas Pharma US, Inc.; production and packaging supply are typically handled by contract manufacturers named on regulatory filings and labeling. To identify the exact current supplier roster (site-level drug-product manufacturing and labeled packager, plus API suppliers), the Orange Book, FDA labeling manufacturing sections, and the underlying chemistry, manufacturing, and controls (CMC) cross-references must be mapped to the relevant application (NDA) and manufacturing changes. No complete, accurate supplier list can be produced from the information provided here.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.